Health Benefits, Costs, and Cost-Effectiveness of Jail-Based Hepatitis C Elimination Strategies - Takeaways - MDSpire

Health Benefits, Costs, and Cost-Effectiveness of Jail-Based Hepatitis C Elimination Strategies

  • By

  • Lin Zhu

  • Lora N. Magaldi

  • Indrani A. Wagh

  • Eliza R. Ennis

  • Marissa B. Reitsma

  • Danica E. Kuncio

  • Eman Addish

  • Sandy R. Varghese

  • Nathan W. Furukawa

  • Amanda A. Honeycutt

  • Yijie Chen

  • Benjamin P. Linas

  • Joshua A. Salomon

  • May 1, 2026

  • 0 min

Share

  • 1

    The US aims to reduce new hepatitis C infections by 90% and related deaths by 65% by 2030, but progress has been limited.

  • 2

    Carceral facilities are critical for engaging people who inject drugs in hepatitis C care due to high substance use disorder prevalence.

  • 3

    Jail-based HCV interventions can enhance public health benefits despite financial disincentives and challenges related to short detention periods.

  • 4

    Direct-acting antiviral treatments improve the feasibility of jail-based HCV interventions, showing high cure rates even with low adherence.

  • 5

    The study evaluated four intervention strategies for HCV management in jails, highlighting the importance of testing and postrelease navigation.

Original Source(s)

Health Benefits, Costs, and Cost-Effectiveness of Jail-Based Hepatitis C Elimination Strategies

  • by Lin Zhu, Lora N. Magaldi, Indrani A. Wagh, Eliza R. Ennis, Marissa B. Reitsma, Danica E. Kuncio, Eman Addish, Sandy R. Varghese, Nathan W. Furukawa, Amanda A. Honeycutt, Yijie Chen, Benjamin P. Linas, Joshua A. Salomon

  • May 1, 2026

Related Content

Lawmakers add ID requirement to Indiana’s needle exchanges

GLP-1 Drugs Linked to GI Effects, Uncertain Signals

Umbrella review evaluates over 1,700 trials to assess noncardiometabolic outcomes beyond weight and glycemic effects.

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.